Pfizer (PFE) Revenue (2009 - 2026)
Pfizer's Revenue was $16.58 billion in Q3 2026, down 0.4% from $16.65 billion a year earlier but up 10.3% from the prior quarter.
Pfizer (PFE) Revenue (2009 - 2026) Analysis & Trends
On a trailing twelve-month basis, Pfizer's Revenue was $63.63 billion through Sep 27, 2026, up 1.3% year-over-year; for FY2025, it came in at $62.58 billion, down 1.6% from FY2024.
- Revenue shows a five-year compound annual growth rate of 8.5% (FY2020 to FY2025).
- In earlier years, Revenue was $63.63 billion in FY2024 (+6.8%), $59.55 billion in FY2023 (-41.1%), $101.18 billion in FY2022 (+24.5%) and $81.29 billion in FY2021 (+95.2%).
- Quarterly Revenue has moved between -$301 million (Q4 2021) and $27.74 billion (Q2 2022) over five years.
- Compared with a year earlier, Revenue was higher in three of the last seven quarters, with growth averaging 0.4%.
- The best year-over-year quarter for Revenue over five years was Q1 2022 (growth of 76.8%); the worst was Q2 2023 (a decline of 53.1%).
- Per Business Quant data, PFE's Revenue in the three quarters before Q3 2026 was $15.03 billion (Q2 2026), $14.45 billion (Q1 2026) and $17.56 billion (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | PetVivo Holdings | 3,096.39 Bn | 3,096.39 Bn | 196,075.00 | 212,806.00 |
| 2 | Eli Lilly | 1,202.70 Bn | 1,176.32 Bn | 20.46 Bn | 24.40 Bn |
| 3 | Johnson & Johnson | 649.77 Bn | 569.63 Bn | 17.30 Bn | 25.40 Bn |
| 4 | AbbVie | 507.00 Bn | 475.00 Bn | 13.12 Bn | 17.40 Bn |
| 5 | Merck | 329.70 Bn | 292.64 Bn | 13.19 Bn | 18.09 Bn |
| 6 | Novartis Ag | 291.91 Bn | 265.14 Bn | - | - |
| 7 | Amgen | 236.26 Bn | 187.91 Bn | 7.58 Bn | 10.37 Bn |
| 8 | Gilead Sciences | 207.15 Bn | 182.26 Bn | 6.73 Bn | 8.30 Bn |
| 9 | Gsk | 193.54 Bn | 176.38 Bn | - | - |
| 10 | Pfizer | 156.44 Bn | 103.79 Bn | 12.56 Bn | 16.58 Bn |
Historic Data
| Date | Value |
|---|---|
| Sep 27, 2026 | 16.58 Bn |
| Jun 28, 2026 | 15.03 Bn |
| Mar 29, 2026 | 14.45 Bn |
| Dec 31, 2025 | 17.56 Bn |
| Sep 28, 2025 | 16.65 Bn |
| Jun 29, 2025 | 14.65 Bn |
| Mar 30, 2025 | 13.72 Bn |
| Dec 31, 2024 | 17.76 Bn |
| Sep 29, 2024 | 17.70 Bn |
| Jun 30, 2024 | 13.28 Bn |
| Mar 31, 2024 | 14.88 Bn |
| Dec 31, 2023 | -80.00 Mn |
| Oct 1, 2023 | 13.49 Bn |
| Jul 2, 2023 | 13.01 Bn |
| Apr 2, 2023 | 18.49 Bn |
| Dec 31, 2022 | 25.14 Bn |
| Oct 2, 2022 | 22.64 Bn |
| Jul 3, 2022 | 27.74 Bn |
| Apr 3, 2022 | 25.66 Bn |
| Dec 31, 2021 | -301.00 Mn |
Pfizer Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=PFE&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "PFE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=PFE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();